Biologically Accurate Synthetic cfDNA For Genomics Research

Biologically accurate, reference-backed cell-free DNA across 107 genetic conditions. Built for NIPT algorithm development, method validation, and genomics research.

Funded by Emergent VenturesValidated against standard NIPT detection methods

Biologically Accurate

92.9% distributional match to real cfDNA. Reference-backed hg38 sequences validated through alignment and detection pipelines.

92.9%distribution match

Comprehensive Coverage

107 genetic conditions across 7 categories — aneuploidies, microdeletions, microduplications, monogenic disorders, oncology hotspots, repeat expansions, and imprinting disorders.

107conditions

Research Ready

Perfect ground truth labels. Privacy-preserving. Platform-agnostic — works with existing NIPT pipelines and lab systems.

95%+alignment rate

Two Products, One Mission

In Development

AI-Enhanced Prenatal Testing

Clinical Platform — Coming Soon

  • Targeting ultra-low foetal fraction analysis (1-2%)
  • 107 condition screening in a single test
  • Population-specific risk assessment
  • Real-time quality assessment and confidence scoring
107Genetic conditions modelled
92.9%Distributional match to real cfDNA
100%T21 detection sensitivity
95%+BWA alignment rate

How It Works

01

Configure

Specify conditions, foetal fraction, fragment depth, and output format for your synthetic samples

02

Generate

Reference-backed cfDNA fragments with biologically accurate size distributions, GC content, and condition-specific signals

03

Validate & Use

Ground-truth labelled data ready for algorithm development, method validation, or ML model training

Ready to Get Started?

Whether you need synthetic cfDNA data for algorithm development and validation, or are interested in our clinical prenatal testing platform in development, we are accepting enquiries.